MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
107
Unique beneficiaries
—
Total services
22,557
Distinct HCPCS
3
Medicare payment
$792K
PRESCRIBING · PART D · 2024
Total Rx claims
13
Beneficiaries
—
Total drug cost
$228K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Immun Glob G(Igg)/Pro/Iga 0-5013 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
83.7
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
1.05%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$8K
Payment records
14
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$7K
Travel and Lodging$1K
Food and Beverage$120
Top paying entities
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$7K
Travel and Lodging$1K
Food and Beverage$120
REFERRAL NETWORK
Where Thu Tran's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Unilab Corporation Clinical Laboratory · West Hills, CA | 13 | 41 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| UNIVERSITY OF CALIFORNIA IRVINE | 38 | 226 |
| Sudhir Gupta Allergy/ Immunology · Irvine, CA | 38 | 226 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 14 | 32 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE